![](/img/cover-not-exists.png)
Grp78 as a therapeutic target for refractory head–neck cancer with CD24−CD44+ stemness phenotype
Chiu, C-C, Lee, L-Y, Li, Y-C, Chen, Y-J, Lu, Y-C, Li, Y-L, Wang, H-M, Chang, J T, Cheng, A-JVolume:
20
Language:
english
Journal:
Cancer Gene Therapy
DOI:
10.1038/cgt.2013.64
Date:
November, 2013
File:
PDF, 883 KB
english, 2013